A PHARMACOECONOMIC EVALUATION OF ROMIPLOSTIM (NPLATE®) FOR THE TREATMENT OF CHRONIC IMMUNE THROMBOCYTOPENIA (ITP) IN MEXICO

被引：1
|
作者：
Arocho, R. [1 ]
Northridge, K. [2 ]
Rivera Hurtado, R. [3 ]
Garcia Chavez, J. [4 ]
机构：
[1] Amgen Inc, Barcelona, Spain
[2] Outcomes Insights Inc, Westlake Village, CA USA
[3] Amgen Mexico, Mexico City, DF, Mexico
[4] Mexican Inst Social Secur IMSS, Mexico City, DF, Mexico
来源：
VALUE IN HEALTH | 2011年 / 14卷 / 03期
关键词：
D O I：
10.1016/j.jval.2011.02.350
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A62 / A62
页数：1
相关论文
共 50 条
  • [1] Romiplostim in children with chronic immune thrombocytopenia (ITP): the French Experience
    Pasquet, Marlene
    Aladjidi, Nathalie
    Guiton, Corinne
    Courcoux, Mary-France
    Munzer, Martine
    Auvrignon, Anne
    Lutz, Patrick
    Ducassou, Stephane
    LeRoy, Gwennaelle
    Munzer, Caroline
    Leverger, Guy
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (02) : 266 - 271
  • [2] Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP).
    Lyons, Roger M.
    Boccia, Ralph V.
    Macik, Gail
    Mandanas, Romeo A.
    Wang, Xuena
    Lizambri, Richard
    Berger, Dietmar
    [J]. BLOOD, 2009, 114 (22) : 1362 - 1362
  • [3] ECONOMIC EVALUATION OF ROMIPLOSTIM VS ELTROMBOPAG IN THE TREATMENT OF ADULT PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA IN MEXICO
    Naranjo, M.
    Alva, M. E.
    Carlos, F.
    [J]. VALUE IN HEALTH, 2017, 20 (09) : A893 - A893
  • [4] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    David J. Kuter
    Cynthia Macahilig
    Kelly M. Grotzinger
    Sara A. Poston
    Peter Feng Wang
    Katie L. Dawson
    Melea Ward
    [J]. International Journal of Hematology, 2015, 101 : 255 - 263
  • [5] Treatment patterns and clinical outcomes in patients with chronic immune thrombocytopenia (ITP) switched to eltrombopag or romiplostim
    Kuter, David J.
    Macahilig, Cynthia
    Grotzinger, Kelly M.
    Poston, Sara A.
    Wang, Peter Feng
    Dawson, Katie L.
    Ward, Melea
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2015, 101 (03) : 255 - 263
  • [6] Romiplostim for the treatment of adults with chronic immune thrombocytopenia
    Terrail, Nicolas
    [J]. EJHP PRACTICE, 2009, 15 (03): : 70 - 73
  • [7] Treatment of chronic immune thrombocytopenia in children with romiplostim
    Chaturvedi, Shruti
    McCrae, Keith R.
    [J]. LANCET, 2016, 388 (10039): : 4 - 6
  • [8] Patient Reported Outcomes Comparison of Chronic Immune Thrombocytopenia (ITP) Patients Switched to Promacta and Nplate
    Kuter, David J.
    Wang, Feng
    Dawson, Katie L.
    Grotzinger, Kelly M.
    Macahilig, Cynthia P.
    [J]. BLOOD, 2011, 118 (21) : 966 - 967
  • [9] COST EFFECTIVENESS OF ROMIPLOSTIM FOR THE TREATMENT OF IMMUNE THROMBOCYTOPENIA (ITP) PATIENTS IN THE CZECH REPUBLIC
    Brezina, T.
    Klimes, J.
    Dolezal, T.
    Maskova, H.
    Campioni, M.
    Kutikova, L.
    [J]. VALUE IN HEALTH, 2014, 17 (07) : A533 - A533
  • [10] Long-Term Safety Profile of Romiplostim in Patients with Chronic Immune Thrombocytopenia (ITP)
    Liebman, Howard
    Henry, David
    Lefrere, Francois
    Viallard, Jean-Francois
    Lichtin, Alan
    George, James
    Sanz, Miguel
    Zhang, Kathy
    Rutstein, Mark
    [J]. BLOOD, 2008, 112 (11) : 1171 - 1171
12345